Elisabeth Hertle
Overview
Explore the profile of Elisabeth Hertle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xin Y, Hertle E, van der Kallen C, Vogelzangs N, Arts I, Schalkwijk C, et al.
J Clin Lipidol
. 2021 Feb;
15(2):311-319.
PMID: 33612457
Background: Plasma lipoproteins contain heterogeneous subclasses. Previous studies on the associations of the complement system with lipids and lipoproteins are mainly limited to the major lipid classes, and associations of...
2.
Xin Y, Hertle E, van der Kallen C, Schalkwijk C, Stehouwer C, van Greevenbroek M
Diabetologia
. 2020 Jan;
63(5):1032-1042.
PMID: 31993713
Aims/hypothesis: Reactive α-dicarbonyl compounds are major precursors of AGEs and may lead to glycation of circulating and/or cell-associated complement regulators. Glycation of complement regulatory proteins can influence their capacity to...
3.
Xin Y, Hertle E, van der Kallen C, Schalkwijk C, Stehouwer C, van Greevenbroek M
Endocrine
. 2018 Aug;
62(3):617-627.
PMID: 30132263
Purpose: We investigated the associations of components of the alternative (C3, C3a, Bb, factor D [FD], factor H [FH], properdin) and the classical complement pathway (C4, C1q, C1-inhibitor [C1-INH]) with...
4.
Hertle E, Arts I, van der Kallen C, Feskens E, Schalkwijk C, Stehouwer C, et al.
Arterioscler Thromb Vasc Biol
. 2018 Mar;
38(5):1242-1244.
PMID: 29567681
Objective: The classical complement pathway has been assigned both protective and pathological effects in cardiovascular disease (CVD), but human data are lacking. We determined the associations of the pattern recognition...
5.
Xin Y, Hertle E, van der Kallen C, Schalkwijk C, Stehouwer C, van Greevenbroek M
Obes Res Clin Pract
. 2017 Nov;
12(3):286-292.
PMID: 29174517
Objective: To investigate longitudinal associations of components of the alternative (C3, C3a, Bb, factor D [FD], factor H [FH], and properdin) and the terminal complement pathway (C5a, sC5b-9) with adiposity....
6.
Hertle E, Arts I, van der Kallen C, Feskens E, Schalkwijk C, Hoffmann-Petersen I, et al.
Arterioscler Thromb Vasc Biol
. 2016 Apr;
36(6):1278-85.
PMID: 27055907
Objective: Previous studies suggested that the lectin-complement pathway plays a complex role in cardiovascular disease (CVD). To date, no prospective human studies have investigated the relationship between the initiating factor...
7.
Hertle E, Arts I, van der Kallen C, Feskens E, Schalkwijk C, Stehouwer C, et al.
Thromb Haemost
. 2015 Oct;
115(2):446-57.
PMID: 26446431
The alternative pathway of complement activation is highly reactive and can be activated spontaneously in the vasculature. Activation may contribute to vascular damage and development of cardiovascular disease (CVD). We...
8.
Hertle E, Van Greevenbroek M, Arts I, van der Kallen C, Geijselaers S, Feskens E, et al.
Thromb Haemost
. 2014 Feb;
111(6):1102-11.
PMID: 24500020
Complement C3 is a novel risk factor for cardiovascular disease (CVD), but the underlying mechanism is currently unknown. We determined the associations of the anaphylatoxin C3a, the activation product of...
9.
Groen B, Res P, Pennings B, Hertle E, Senden J, Saris W, et al.
Am J Physiol Endocrinol Metab
. 2011 Sep;
302(1):E52-60.
PMID: 21917635
The loss of skeletal muscle mass with aging has been attributed to an impaired muscle protein synthetic response to food intake. Therefore, nutritional strategies are targeted to modulate postprandial muscle...